Translational Regenerative Medicine Market Set to Surpass $77 Billion in 2024 [Yahoo! Finance]
![Yahoo! Finance](../../../Content/images/providers/Yahoo! Finance.png)
Avita Medical, Inc. (RCEL)
Company Research
Source: Yahoo! Finance
Overall world revenue for the Translational Regenerative Medicine Market, is set to surpass US$77 billion in 2024, with strong revenue growth through to 2034. Rising Chronic Diseases Driving Industry Growth The global landscape of healthcare is witnessing a paradigm shift driven by the escalating prevalence of chronic diseases. Conditions such as cardiovascular diseases, diabetes, neurodegenerative disorders, and autoimmune diseases pose a significant burden on healthcare systems worldwide. In response to this growing health crisis, the field of Translational regenerative medicine (TRM) has emerged as a beacon of hope, offering innovative solutions to address the root causes of these chronic ailments. Translational regenerative medicine focuses on harnessing the body's innate regenerative capabilities to repair, replace, or regenerate damaged tissues and organs. Stem cell therapies, tissue engineering, and other regenerative approaches hold the potential to revolutionize the tr
Show less
Read more
Impact Snapshot
Event Time:
RCEL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RCEL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RCEL alerts
High impacting Avita Medical, Inc. news events
Weekly update
A roundup of the hottest topics
RCEL
News
- AVITA Medical Achieves Milestone with First Case Using RECELL GO [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Achieves Milestone with First Case Using RECELL GOGlobeNewswire
- Avita obtains FDA approval for cell harvesting device Recell GO System [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Announces FDA Approval of RECELL GO [Yahoo! Finance]Yahoo! Finance
- AVITA Medical Announces FDA Approval of RECELL GOGlobeNewswire
RCEL
Earnings
- 5/13/24 - Miss
RCEL
Sec Filings
- 6/6/24 - Form 4
- 6/6/24 - Form 4
- 6/6/24 - Form 4
- RCEL's page on the SEC website